Adipose Tissue Lipolysis and Alcoholic Fatty Liver
脂肪组织脂解与酒精性脂肪肝
基本信息
- 批准号:8317733
- 负责人:
- 金额:$ 28.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-30 至 2014-08-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAdipocytesAdipose tissueAdrenergic ReceptorAffectAlcohol consumptionAlcoholic Fatty LiverAlcoholic Liver DiseasesAlcoholismAlcoholsAttenuatedBody fatCD36 AntigensCD36 geneChronicClinical ResearchCoupledCyclic AMPCyclic AMP-Dependent Protein KinasesDataDepositionDevelopmentDietary ZincDiseaseFatty AcidsFatty LiverFatty acid glycerol estersFatty-acid synthaseFibrosisGlucocorticoidsHepaticHepatic MassHepatitisHepatocyteHomeostasisInflammation MediatorsLeadLinkLipaseLipidsLipoatrophyLipolysisLiverMediatingMetabolic syndromeMetabolismMolecularMusNamesNicotinic AcidsPathogenesisPathway interactionsPatientsPlayPrincipal InvestigatorProductionProteinsRegulationResearchRoleSignal TransductionSupplementationTestingTriglyceridesUp-RegulationZincZinc deficiencyalcohol exposureattenuationdeprivationfatty acid transportfeedingproblem drinkerprogramspublic health relevancereceptorsterol esterasetranslocaseuptake
项目摘要
DESCRIPTION (provided by applicant): Adipose tissue lipolysis and alcoholic fatty liver Project Summary Alcoholic fatty liver is one of the earliest pathological changes in the progression of alcoholic liver disease. Accumulation of lipid in the hepatocyte makes the liver susceptible to inflammatory mediators or other toxic agents, leading to further progression to hepatitis and eventually fibrosis. Therefore, lipid accumulation is one of the most fundamental cellular disorders in alcoholic liver disease, and reduction of liver fat would likely halt or slow the progression of alcoholic liver disease. While alcohol induces fat accumulation in the liver, a significant decrease in fat mass (lipoatrophy) has been documented in chronic alcoholism. Our preliminary studies demonstrated a negative correlation between adipose tissue mass and liver fat in mice chronically fed alcohol. We also found that attenuation of alcoholic fatty liver by zinc supplementation is accompanied by partial reversal of lipoatrophy, suggesting a link between lipoatrophy and alcoholic fatty liver. Our recent studies further demonstrated that alcohol exposure upregulated hepatic fatty acid transporter 5 (FATP5) and CD36 (also named fatty acid translocase), suggesting an increased fatty acid uptake in the liver. On the other hand, chronic alcohol exposure activated both hormone sensitive lipase (HSL) and adipose triglyceride lipase (ATGL) pathways in the adipose tissue, indicating an upregulation of lipolysis. Our overall hypothesis is that reverse fatty acid transport due to excess lipolysis of the adipose tissue plays a crucial role in pathogenesis of alcoholic fatty liver. To test this hypothesis, four specific aims are proposed. Aim 1 is to determine if increased fatty acid uptake plays a crucial role in the development of alcoholic fatty liver. We will first document alcohol- induced increase in hepatic fatty acid uptake. We will then determine if blocking fatty acid uptake leads to reduction of alcoholic fatty liver. Aim 2 is to determine if excess lipolysis of the adipose tissue is a causal factor in alcohol-increased hepatic fatty acid uptake. We will first determine if alcohol exposure can enhance hepatic deposition of fatty acids mobilized from adipose tissue. We will then determine if blocking adipose tissue fatty acid mobilization can lead to attenuation of alcoholic fatty liver. Aim 3 is to investigate the molecular mechanisms by which alcohol induces excess lipolysis of the adipose tissue. We will first determine how alcohol exposure affects the lipolytic pathways in the adipose tissue. We will then define the role of nicotinic acid deficiency in HSL activation and the role of glucocorticoid in activation of ATGL lipolytic pathway. Aim 4 is to define the role of zinc in the regulation of adipose tissue lipolysis. We will first determine the effects of dietary zinc on lipolytic pathways and nicotinic acid metabolism and glucocorticoid production. We will then determine how zinc affects lipolytic signaling transduction in the adipocytes.
PUBLIC HEALTH RELEVANCE: Alcoholic fatty liver is the earliest pathological change in the progression of alcoholic liver disease, but the mechanisms by which alcohol causes hepatic lipid accumulation have not been well defined. Clinical studies have shown a significant decrease in fat mass in patients with alcoholic fatty liver. Our preliminary studies demonstrated a negative correlation between liver fat and adipose tissue mass. We also found that alcohol exposure stimulates adipose tissue lipolysis and hepatic fatty acid uptake. This project will test our hypothesis that reverse fatty acid transport due to excess lipolysis of the adipose tissue plays a crucial role in the pathogenesis of alcoholic fatty liver.
描述(由申请人提供):脂肪组织脂解和酒精脂肪肝项目摘要酒精脂肪肝是酒精性肝病进展的最早病理变化之一。脂肪在肝细胞中的积累使肝脏容易受到炎症介质或其他有毒剂的影响,从而进一步发展为肝炎并最终导致纤维化。因此,脂质积累是酒精性肝病中最基本的细胞疾病之一,肝脏脂肪的减少可能会停止或减慢酒精性肝病的进展。虽然酒精会诱导肝脏中的脂肪积累,但在慢性酒精中毒中已记录了脂肪质量(脂肪植物)的显着降低。我们的初步研究表明,小鼠长期喂养酒精的脂肪组织质量与肝脏脂肪之间存在负相关。我们还发现,补充锌对酒精性脂肪肝的衰减伴随着脂肪植物的部分逆转,这表明脂肪植物与酒精脂肪肝之间有联系。我们最近的研究进一步表明,酒精暴露上调肝脂肪酸转运蛋白5(FATP5)和CD36(也称为脂肪酸易位酶),表明肝脏中脂肪酸的摄取量增加。另一方面,慢性酒精暴露激活了脂肪组织中的激素灵敏脂肪酶(HSL)和脂肪甘油三酸酯脂肪酶(ATGL)途径,表明脂肪解的上调。我们的总体假设是,由于脂肪组织过多的脂肪分解而导致的反向脂肪酸转运在酒精脂肪肝发病机理中起着至关重要的作用。为了检验这一假设,提出了四个具体目标。目的1是确定增加脂肪酸摄取量是否在酒精脂肪肝发育中起关键作用。我们将首先记录酒精诱导的肝脂肪酸摄取的增加。然后,我们将确定阻断脂肪酸摄取是否会导致酒精脂肪肝的减少。目的2是确定脂肪组织的过量脂解是否是肝脂肪酸摄取的因果因素。我们将首先确定酒精暴露是否可以增强脂肪组织动员的脂肪酸的肝沉积。然后,我们将确定阻断脂肪组织脂肪酸动员是否会导致酒精脂肪肝的衰减。目的3是研究酒精诱导脂肪组织过量脂解的分子机制。我们将首先确定酒精暴露如何影响脂肪组织中的脂解途径。然后,我们将定义烟酸缺乏在HSL激活中的作用以及糖皮质激素在ATGL脂肪溶解途径激活中的作用。目的4是定义锌在调节脂肪组织脂解中的作用。我们将首先确定饮食锌对脂解途径和烟酸代谢和糖皮质激素产生的影响。然后,我们将确定锌如何影响脂肪细胞中的脂解信号传导转导。
公共卫生相关性:酒精脂肪肝是酒精性肝病进展的最早病理变化,但是酒精引起肝脂质积累的机制尚未得到很好的定义。临床研究表明,酒精脂肪肝患者的脂肪量显着减少。我们的初步研究表明,肝脏脂肪与脂肪组织质量之间存在负相关。我们还发现,酒精暴露会刺激脂肪组织脂解和肝脂肪酸的摄取。该项目将检验我们的假设,即由于脂肪组织的脂肪过量而导致的脂肪酸转运在酒精脂肪肝的发病机理中起着至关重要的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ZHANXIANG ZHOU其他文献
ZHANXIANG ZHOU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ZHANXIANG ZHOU', 18)}}的其他基金
Adipose Tissue Lipolysis and Alcoholic Fatty Liver
脂肪组织脂解与酒精性脂肪肝
- 批准号:
8140619 - 财政年份:2009
- 资助金额:
$ 28.21万 - 项目类别:
Adipose Tissue Lipolysis and Alcoholic Fatty Liver
脂肪组织脂解与酒精性脂肪肝
- 批准号:
8205039 - 财政年份:2009
- 资助金额:
$ 28.21万 - 项目类别:
Zinc inhibition of endotoxemia in alcoholic liver injury
锌对酒精性肝损伤内毒素血症的抑制作用
- 批准号:
8140607 - 财政年份:2009
- 资助金额:
$ 28.21万 - 项目类别:
Adipose Tissue Lipolysis and Alcoholic Fatty Liver
脂肪组织脂解与酒精性脂肪肝
- 批准号:
8517436 - 财政年份:2009
- 资助金额:
$ 28.21万 - 项目类别:
Zinc inhibition of endotoxemia in alcoholic liver injury
锌对酒精性肝损伤内毒素血症的抑制作用
- 批准号:
7860667 - 财政年份:2009
- 资助金额:
$ 28.21万 - 项目类别:
相似国自然基金
脂肪干细胞外泌体miRNA-299a-3p调控巨噬细胞Thbs1缓解脂肪组织衰老的机制研究
- 批准号:82301753
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
CXCL1/CXCR2信号轴上调Bcl-2促进筋膜定植巨噬细胞迁移在皮下脂肪组织原位再生中的机制研究
- 批准号:82360615
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
Arid5b调控Treg细胞脂肪组织适应性发育和代谢调控功能及机制探究
- 批准号:82371752
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
巨噬细胞Lp-PLA2对脂肪组织重塑的调控及其作用机制
- 批准号:32300977
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
巨噬细胞介导脂肪组织重构在塑化剂干扰系统能量代谢中的作用研究
- 批准号:82373625
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Adipokines, Sex Hormones and Cardiac Dysfunction in Postmenopausal Women of the MESA Study – An analysis of Secondary Data
MESA 研究中绝经后妇女的脂肪因子、性激素和心脏功能障碍 — 二手数据分析
- 批准号:
10507719 - 财政年份:2022
- 资助金额:
$ 28.21万 - 项目类别:
Predictors of Recidivism to Obesity in Weight-Reduced Individuals
体重减轻者肥胖累犯的预测因素
- 批准号:
10571766 - 财政年份:2021
- 资助金额:
$ 28.21万 - 项目类别:
Predictors of Recidivism to Obesity in Weight-Reduced Individuals
体重减轻者肥胖累犯的预测因素
- 批准号:
10190515 - 财政年份:2021
- 资助金额:
$ 28.21万 - 项目类别:
Integrative analysis of bulk and single-cell RNA-seq data for cardiometabolic disease
心脏代谢疾病的批量和单细胞 RNA-seq 数据的综合分析
- 批准号:
10448317 - 财政年份:2021
- 资助金额:
$ 28.21万 - 项目类别:
Predictors of Recidivism to Obesity in Weight-Reduced Individuals
体重减轻者肥胖累犯的预测因素
- 批准号:
10652665 - 财政年份:2021
- 资助金额:
$ 28.21万 - 项目类别: